about
Blue-Print Autophagy: Potential for Cancer TreatmentChemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expressionElucidation of how cancer cells avoid acidosis through comparative transcriptomic data analysis.Potentiometric and relaxometric properties of a gadolinium-based MRI contrast agent for sensing tissue pHIdentification of inhibitors of vacuolar proton-translocating ATPase pumps in yeast by high-throughput screening flow cytometry.Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP).Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancerCell growth inhibition and apoptotic effects of a specific anti-RTFscFv antibody on prostate cancer, but not glioblastoma, cellsInhibition of iron uptake is responsible for differential sensitivity to V-ATPase inhibitors in several cancer cell lines.PA1b inhibitor binding to subunits c and e of the vacuolar ATPase reveals its insecticidal mechanismProton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cellsSilencing of TMSG1 enhances metastasis capacity by targeting V-ATPase in breast cancerVacuolar ATPase 'a2' isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancerEnoxacin directly inhibits osteoclastogenesis without inducing apoptosisRational identification of enoxacin as a novel V-ATPase-directed osteoclast inhibitor.pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.Evaluating the potential of vacuolar ATPase inhibitors as anticancer agents and multigram synthesis of the potent salicylihalamide analog saliphenylhalamide.The Function of V-ATPases in CancerFunction of a subunit isoforms of the V-ATPase in pH homeostasis and in vitro invasion of MDA-MB231 human breast cancer cells.HER2/HER3 regulates extracellular acidification and cell migration through MTK1 (MEKK4).Atp6v1c1 may regulate filament actin arrangement in breast cancer cells.The (pro)renin receptor mediates constitutive PLZF-independent pro-proliferative effects which are inhibited by bafilomycin but not genistein.Targeting reversible disassembly as a mechanism of controlling V-ATPase activityRoles of ion transport in control of cell motility.Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance.The influence of pH and hypoxia on tumor metastasis.Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors.Extracellular acidity, a "reappreciated" trait of tumor environment driving malignancy: perspectives in diagnosis and therapy.Osteoclast proton pump regulator Atp6v1c1 enhances breast cancer growth by activating the mTORC1 pathway and bone metastasis by increasing V-ATPase activity.Regulation of V-ATPase assembly and function of V-ATPases in tumor cell invasiveness.Expression and role of V1A subunit of V-ATPases in gastric cancer cells.The Role of pH Regulation in Cancer Progression.Rabeprazole exhibits antiproliferative effects on human gastric cancer cell lines.Silencing of LASS2/TMSG1 enhances invasion and metastasis capacity of prostate cancer cell.Tumor-associated vacuolar ATPase subunit promotes tumorigenic characteristics in macrophages.The marine natural product manzamine A targets vacuolar ATPases and inhibits autophagy in pancreatic cancer cells.Silencing of a novel tumor metastasis suppressor gene LASS2/TMSG1 promotes invasion of prostate cancer cell in vitro through increase of vacuolar ATPase activity.V-ATPase promotes transforming growth factor-β-induced epithelial-mesenchymal transition of rat proximal tubular epithelial cells.KLF6/Sp1 initiates transcription of the tmsg-1 gene in human prostate carcinoma cells: an exon involved mechanism.Interaction between V-ATPase B2 and (Pro) renin Receptors in Promoting the progression of Renal Tubulointerstitial Fibrosis.
P2860
Q26741800-78F937B0-0FCF-4006-87C3-0D2AEF8EC392Q28535295-9118D293-5616-40C9-BA4C-91BBED5D9078Q30662860-2B8E3B42-F019-499A-85FC-7DCAB6B210AEQ31114276-2154A6C5-6AE3-479E-ACEF-DDE4E99F8D85Q33519426-5E3AF995-0C6E-4300-B008-4B5C14EC4295Q33551761-082213A8-87D9-48B7-88DB-2A04CBA65AA7Q33572677-20E30907-97F9-4145-B3C1-05F3A89FBC0FQ33589310-B72F61F7-E1B1-402E-A9B6-40287DE12ECAQ33641308-C61D497B-9785-43E5-9688-C4ADF84B9C37Q33718555-ED362104-FB63-485F-A854-80C85DB7D600Q34561771-3F603DAD-10BD-4FD3-AB8D-098808574001Q35404976-D37A9649-4023-4DF5-8576-B400CEA86E6CQ35551874-40EA42F0-0753-4F2B-BDB3-0AC5B6557340Q36006859-CB23E67C-6A3A-47DC-80A1-611C93B9EDDEQ36131284-6C09440A-2A77-4059-B8ED-AEBB066BC933Q36404430-7FAED4B1-1AF9-40A8-AC71-369BF2E8E1BBQ36994886-53569C28-39B8-4B06-917E-B121175C5A49Q37169505-914FB8CC-6FEF-4D20-8609-9AE1F5B10768Q37269119-A0B8DBC7-E197-4E60-9BE2-A82A869241EAQ37407344-07E3C98C-8523-44D7-8E8F-494CAB1AE56BQ37483783-4A35AE89-057B-42E1-A25B-D099251A105EQ37685401-A07424FA-2933-4E03-82D4-7C861B23A812Q37951590-C2980C78-8DC3-4314-9A36-72C2A9A83523Q38110508-8EE5CDFC-3A97-474D-AEEB-F514178B01D2Q38132359-8B8C124A-B1AA-41BB-81ED-CE17424600C1Q38149984-548706AF-4E1C-4877-91AE-9931EB5A4E3AQ38177264-5799AB0A-F755-46B6-8273-5C5F71C4F084Q38225316-5100CC21-CE39-4949-9FE0-55F1481D5D01Q38703517-379A75DE-ECDA-450B-A33F-86A5F5F85AA6Q38746834-FE4FD2BA-1EAB-49D7-A812-F534C59AC864Q38912831-08FF061B-7936-4809-A4E7-E993D55BFEF3Q38936259-EC356AF3-E67C-410F-8FA5-165AEF165FF6Q38958255-E8279A73-49A9-4356-8035-9F1792D6A08EQ39031586-EE685C6A-C4A0-4813-BB90-A6E78113367FQ39041039-7A6A66F2-B86E-48D9-A3A5-642202EF0889Q39094315-66E3E4B1-D519-4174-AD92-22CD062F037DQ39351097-6165669B-38A0-4E1F-B3D9-39B58B96A532Q39435290-24BDCDCB-08DB-4D60-8C94-6E860331BEE9Q39471980-8EEA46DF-9CD3-41ED-9861-F3F357E519CDQ39816990-15D4D19E-91AC-4CC4-84DC-77EE0D289974
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Plasmalemmal vacuolar-type H+-ATPase in cancer biology.
@ast
Plasmalemmal vacuolar-type H+-ATPase in cancer biology.
@en
type
label
Plasmalemmal vacuolar-type H+-ATPase in cancer biology.
@ast
Plasmalemmal vacuolar-type H+-ATPase in cancer biology.
@en
prefLabel
Plasmalemmal vacuolar-type H+-ATPase in cancer biology.
@ast
Plasmalemmal vacuolar-type H+-ATPase in cancer biology.
@en
P2093
P356
P1476
Plasmalemmal vacuolar-type H+-ATPase in cancer biology.
@en
P2093
Defeng Luo
Raul Martínez-Zaguilán
Souad R Sennoune
P2888
P304
P356
10.1385/CBB:40:2:185
P577
2004-01-01T00:00:00Z
P6179
1005006215